Gossamer Bio Inc. (GOSS)
NASDAQ: GOSS
· Real-Time Price · USD
2.56
-0.07 (-2.66%)
At close: Oct 01, 2025, 1:53 PM
-2.66% (1D)
| Bid | 1.93 |
| Market Cap | 583.23M |
| Revenue (ttm) | 40.24M |
| Net Income (ttm) | -138.74M |
| EPS (ttm) | -0.59 |
| PE Ratio (ttm) | -4.35 |
| Forward PE | -6 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.3 |
| Volume | 2,161,289 |
| Avg. Volume (20D) | 3,583,826 |
| Open | 2.59 |
| Previous Close | 2.63 |
| Day's Range | 2.56 - 2.70 |
| 52-Week Range | 0.66 - 3.60 |
| Beta | 1.95 |
| Ex-Dividend Date | n/a |
About GOSS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GOSS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GOSS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsGossamer Bio Inc. is scheduled to release its earnings on
Nov 6, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+12.27%
Gossamer Bio shares are trading higher after UBS u...
Unlock content with
Pro Subscription
1 month ago
-8.33%
Gossamer shares are trading lower. The company reported Q2 financial results.
